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Summary
Objective: To evaluate a 10-year school-based latent tuberculosis infection (LTBI)
screening program, targeting immigrant children in Montreal, Canada, and to iden-
tify predictive factors for refusal and, poor adherence to treatment.
Methods: Immigrant children were screened for LTBI with Tuberculin Skin Test (TST).
Isoniazid was, given when LTBI was diagnosed. Predictors of LTBI, of refusal of follow-
up and treatment and of poor, adherence to isoniazid were analyzed.
Results: Four thousand three hundred and seventy-ﬁve children were offered screen-
ing, 82.3% consented to TST and 22.8% were positive. An, older age at migration
(odds ratio (OR) = 1 [95% CI: 1.0—1.01]), as well as migration from a none, established
market economy country (OR varying from 2.41 to 4.23) were signiﬁcantly associated
with, positive TST. Among positive children, further evaluation was refused in 5.7%,
mainly in migrants from, Eastern Europe (OR = 4.05 [95% CI: 2.14—7.69]). Refusal of
treatment (11.2%) was more frequent in, Eastern European when compared to South-
eastern Asian (OR = 6.91 [95% CI: 1.56—30.75]), in, blended families (OR = 3.25 [95%
CI: 1.25—8.46]) and when the ﬁrst visit to hospital was delayed (OR = 1.01 [95% CI:
1.0—1.02]). Adequate completion of treatment was noted in 61.3%. Age > 16 years
(OR = 1.82 [95% CI: 1.82—2.99]), a delay between TST and ﬁrst visit > 15 days (OR = 1.6
Abbreviations: TB, tuberculosis; LTBI, latent tuberculosis infection; TST, tuberculin skin test; BCG, bacillus Calmette-Guérin;
OR, odds ratio; CI, conﬁdence interval.
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[95% CI: 1.12—2.28]), as well as the presence of relative > 18 years in the household
(OR = 1.56 [95% CI: 1.0—2.43]), were associated with poor adherence to treatment.
Conclusion: Sociocultural and behavioural factors are involved in acceptance of LTBI
treatment in, immigrant children. Adherence to treatment is challenging and requires
comperhension of sociocultural beliefs and accessibility to TB clinic.
dulaziz University for Health Sciences. Published by Elsevier
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>18 years living in the household), siblings under 18
years living in the household, refugee status (Cana-
dian, permanent resident, refugee), known contact© 2010 King Saud Bin Ab
Ltd. All rights reserved.
Targeted tuberculin skin testing is an important
part of tuberculosis (TB) control strategy in low
burden countries [1,2]. Latent tuberculosis infec-
tion (LTBI), which is deﬁned as a positive tuberculin
skin test (TST) and no evidence of TB disease, has
to be detected and treated to prevent extension
and dissemination of TB, especially in children.
Indeed, lifelong risk of reactivation is about 10—20%
in young children and adolescents with TST ≥10mm
[3]. LTBI is frequent in people emigrating from
highly endemic countries [1,4]. In Québec, Canada,
the incidence of active TB was 3.4/100,000 in
2003 but almost 7 times higher in areas of Mon-
treal, a city in which immigrants concentrate [5].
Although foreign-born people represent only 9.9%
of Québec’s population, they account for 61.7%
of TB cases. In immigrant children, active TB
annual incidence was 43/100,000 in 15—19-year
olds and 6/100,000 in 1—4-year olds in 2000—2003
[5]. Considering the TB risk in immigrant children,
a prospective school-based TB-screening program
was implemented in 1997 at Sainte Justine Hospi-
tal, a large pediatric tertiary care teaching hospital
in Montréal, Québec (Canada). The program tar-
geted immigrant children living in the most densely
populated area of the city. In this area, immigrants
actually represent 45% of the total population, and
half of them have entered Canada in the last 10
years. Although 45% of immigrants had some univer-
sity education, half have an annual income <15000
Ca$ [6].
In Québec, most immigrant children are not
ﬂuent in French and are placed in welcoming
classes to learn the common language, whereas
French-speaking immigrants usually attended reg-
ular classes. The TB-screening program selected
both welcoming classes and regular classes with
immigrants. A 10-year analysis of the program was
performed.
LTBI was deﬁned and treated in accordance to
current Canadian guidelines [7]. As adherence is
challenging in pediatric LTBI treatment [8—15], we
tried to identify factors contributing to acceptance
and to completion of treatment.
w
v
wethods
he TB-screening program
n selected classes, school nurses informed children
nd parents about TB-screening by mail. Written
arents’ consent was collected before testing for
hildren aged less than 14 years old. On the planned
ay, consent of each child was required.
A trained nurse from the TB-Clinic of Sainte Jus-
ine Hospital visited the children at school and
sked them for their age, country of birth, age
t emigration, and foreign countries where they
ad resided. Children in ﬁfth and sixth grades
10—12 years old) in primary schools were specif-
cally targeted for screening. Only two of those
rained nurses were involved in the program dur-
ng the period. They also performed TST using the
antoux technique, according to Canadian tubercu-
osis standards [16]. Five Tuberculin Units (0.1ml)
f puriﬁed protein derivative standard (Tubersol®,
anoﬁ Pasteur) were injected in the dermis of the
eft forearm. TST were read using the ‘‘ball point’’
echnic, 48 h later at school by the TB-nurse. A pos-
tive TST was deﬁned as an induration ≥10mm in
ransverse diameter at the site of injection. Previ-
us bacillus Calmette-Guérin (BCG) vaccination was
ot taken into account for TST interpretation. On
he day of TST reading, children with positive TST
ere scheduled for a follow-up appointment in the
B-Clinic of Sainte Justine Hospital.
The day of the ﬁrst visit at the TB-Clinic, all the
ST positive children underwent a chest X-ray and
medical evaluation. Chest X-rays were read by
paediatric radiologist. Gender, age, age at time
f immigration, country of birth, foreign travels,
ative language, ability to speak French or English,
ype of family (presence of the parents, relativesith TB-infected persons, BCG vaccination and pre-
ious TB evaluation and treatment were recorded
ith families. BCG vaccine status was evaluated
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ooking at any existing documentation, such as
vaccination record, and/or by the presence of
cars on BCG vaccine common sites. Patients with
ctive TB were not included in the study. Children
ith LTBI were offered treatment with isoniazid
0—15mg/kg/d (max. 300mg/d), if not contra-
ndicated by history and physical examination. The
lanned duration of treatment was 6 months from
997 to 2000, then changed to 9 months following
report of the Centers for Disease Control & Pre-
ention [17]. If treatment was accepted, a 6 (then
)-month isoniazid supply was prescribed and dis-
ributed each month. Visits at TB-Clinic were sched-
led at 1, 3, 6 and 9 months of treatment. When an
ppointment was missed, a TB-clinic nurse phoned
he family to schedule another appointment.
reatment withdrawal was considered when no con-
act with family was obtained after two phone
alls and two letters. When INH treatment was
efused, children were discharged after medical
ounseling.
Adherence to isoniazide was evaluated by: 1)
y self-reported adherence at each appointment
doses usually taken during a week, i.e. 0—7
oses/7 days), 2) by pills counts whenever possible,
) by phone calls to pharmacies during treatment in
rder to verify regular medication supplies. Adher-
nce was considered adequate if the child took
80% of the prescribed doses in a time ≤120% of
he duration planned at ﬁrst visit (i.e. 29 weeks
or a 6 months treatment and 43 weeks for a 9
onths one). The threshold of 80% of the dose
s commonly chosen for good adherence [18]. As
thers [15], we have added limits in the dura-
ion of treatment to include children that had
aken all the doses in a slightly longer time. How-
ver, when it took a very long time (>120% of the
lanned duration) to assess ≥80% of the prescribed
oses, children were considered poor compliant.
omplaints during treatment were noted at each
ppointment. Finally, when the treatment was com-
lete, a certiﬁcate was given and the child was
ischarged.
ata collection
ata was collected prospectively using the standard
B-Clinic form sheets, which were then trans-
erred anonymously onto a computerized database
SPSS 15.0 for Windows). Countries of migration
ere grouped according to WHO subregions [19].
omplaints during treatment were compiled with
o regard to potential causality. This study was
pproved by the local ethics committee and the
nstitutional review board.
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tatistics
PSS 15.0 for Windows was used for statistics. For
ategorical data and group means comparisons, we
sed a binary regression model. Independent clin-
cal and biological data that were signiﬁcant or
lose to signiﬁcance in univariate analysis were
hen retained for a multivariate logistic regres-
ion analysis. The signiﬁcance p value always was
< 0.05.
esults
rom 1997 to 2007, 4375 children in 21 schools were
ffered TB-screening. Seven hundred and seventy-
hree (17.7%) refused testing. Three thousand six
undred and two consenting children received TST
nd 3401 tests (94.4%) were read, of which 777
22.8%) were ≥10mm. The mean age of screened
hildren was 146 (S.D. ±33) months, 52% were
ales.
Data was available for analysis in 724 children
93.2%). Forty-one children (5.7%) refused the ﬁrst
B-clinic visit. Among the 683 evaluated children,
one had chest X-ray compatible with active TB.
CG vaccination was reported in 89%. Thirty-eight
hildren (5.6%) had been previously treated for LTBI
nd were discharged. Seventy-two (11.2%) refused
o be treated. Isoniazid was prescribed in 573 chil-
ren. Twenty-eight children (4.9%) were referred to
nother hospital during the follow-up. Among the
45 evaluable children (70.1% of all the positive
ST), 334 (61.3%) ﬁnally completed the treatment
ith an adequate adherence. Fig. 1 summarizes the
chool-based TB-screening.
isk factors for LTBI
ompared to children born in an established market
conomy country (Canada, United States, West-
rn Europe and Israel mainly), children emigrating
rom Eastern Europe, African countries with high
IV prevalence, Latin America, the Western Paciﬁc
egion, Central Europe, African countries with low
IV prevalence, the Eastern Mediterranean region
r South-eastern Asia were signiﬁcantly more likely
o have TST ≥10mm, both in univariate and mul-
ivariate analysis (Fig. 2). Mean ages at emigration
as 118 (S.D. ±49) months. Rates of positive TSTncreased with age at emigration (Fig. 3). Odds
atio (OR) and 95% conﬁdence intervals (95% CI)
re reported in Table 1. Compared to TST nega-
ive children by amultivariate analysis, mean age at
ime of emigration was signiﬁcantly higher among
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Figure 1 School-based LTB1 screening program (1997—2007).
Figure 2 Number of children tested according to WHO subregions of migration and percents of TST≥ 10mm.
Immigrants with latent tuberculosis infection 71
Figure 3 Rates of TST≥ 10mm according to age at time of migration.
Table 1 Features associated with a positive TST risk (TST≥ 10mm).
TST≥ 10mm TST < 10mm Univariate analysis,
OR [95% CI]
Multivariate
analysis, OR [95% CI]
Country of migration (n/%)a
Established market economy 29 (2.7) 1062 (97.3) 1 1
South east Asia 92 (26) 262 (74) 12.86 [8.29—19.94] 2.41 [1.15—5.06]
East Mediterranean 59 (27.1) 159 (72.9) 13.59 [8.45—21.85] 2.65 [1.23—5.69]
Africa low HIV 34 (31.5) 74 (68.5) 16.83 [9.72—29.12] 3 [1.33—6.78]
Central Europe 16 (32) 34 (68) 17.23 [8.56—34.68] 3 [1.18—7.64]
Western Paciﬁc 203 (32.8) 416 (67.2) 17.87 [11.92—26.8] 3.44 [1.67—7.08]
Latin America 146 (37.6) 242 (62.4) 22.09 [14.48—33.7] 4.03 [1.93—8.39]
Africa high HIV 19 (38) 31 (62) 22.45 [11.37—44.3] 3.9 [1.57—9.73]
East Europe 174 (39.4) 268 (60.6) 23.78 [15.7—36.02] 4.23 [2.04—8.77]
Mean age at TST (months) 153 (±32) 144 (±32) [1.01—1.01] 1 [1—1.01] (NS)
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NS: non-signiﬁcant.
a Grouped according to WHO subregion [19].
ST positive children (126 (S.D. ±48) months ver-
us 114 (S.D. ±49) months, OR = 1 [95% CI: 1—1.01]).
ean age at time of the TST testing was signiﬁcantly
igher among positive children in univariate anal-
sis only (153 (S.D. ±35) months versus 144 (S.D.
32) months, OR = 1.01 [95% CI: 1.01—1.01]).
efusal of the initial visit at TB-Clinic
orty-one children (5.7% of evaluable positive
hildren) refused to visit the TB-Clinic. Eastern
uropean people were more likely to refuse the
isit than others (OR = 4.05 [95% CI: 2.14—7.69])
hereas those from the Western Paciﬁc were more
ikely to accept (OR = 0.21 [95% CI: 0.07—0.69]).
ussian (5.5% of TST positive but 12.2% of refusals),
s
f
e
a
o49) 1.01 [1—1.01] 1 [1—1.01]
krainian (3.5% and 12.2%), Moldavian (2.3% and
.8%) and Bulgarian (3.1% and 7.3%) children were
he most frequent to refuse the TB-Clinic visit.
efusal of treatment
reatment was refused by 72 children (11.2% of chil-
ren visiting TB-Clinic and not previously treated).
n children emigrating from South-eastern Asia
nd Eastern Europe, treatment refusal rates were
espectively 3.6% and 23.7%. In univariate analy-
is, signiﬁcant features for refusal were emigrating
rom Eastern Europe (when compared to South-
astern Asia), living with one of the parents and
parent in law (blended family) and having no
r only one sibling <18 years at home. The mean
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Table 2 Features associated with refusal of treatment (non-signiﬁcant features in univariate analysis were not
reported in the table).
Treatment’s
refusal, n (%)
or mean (S.D.)
Treatment’s
acceptance, n (%)
or mean (S.D.)
Univariate analysis,
OR [95% CI]
Multivariate
analysis, OR [95% CI]
Place of migration
South east Asia 3 (4.2) 81 (13.3) 1 1
East Europe 32 (44.4) 103 (16.9) 8.39 [2.48—28.38] 6.91 [1.56—30.75]
Blended family 7 (12.7) 23 (3.8) 3.67 [1.50—8.98] 3.25 [1.25—8.46]
>2 children under 18 at home 6 (10.9) 191 (31.6) 0.27 [0.11—0.63] 0.42 [0.17—1.05] (NS)
Mean delay TST/ﬁrst visit 28.6 (32.5) 21.8 (20.5) 1.01 [1—1.02] 1.01 [1—1.02]
NS: non-signiﬁcant.
Table 3 Features associated with poor adherence to LTBI treatment (non-signiﬁcant features in univariate analysis
were not reported in the table).
Adequate
completion, n (%)
Incomplete
completion, n
(%)
Univariate analysis,
OR [95% CI]
Multivariate
analysis, OR [95% CI]
Age >16 years 37 (11.1) 40 (19) 1.88 [1.16—3.05] 1.82 [1.11—2.99]
Delay TST-Visit >15 days 166 (50.2) 129 (61.1) 1.56 [1.1—2.22] 1.6 [1.12—2.28]
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pPresence relatives >18
years in household
54 (16.2) 49 (23
Adequate completion was deﬁned as ≥80% of total dose in a d
delay between the TST and the ﬁrst visit to the TB-
Clinic was also signiﬁcantly longer among refusing
children. In multivariate analysis, signiﬁcant inde-
pendent factors for refusal were Eastern European
origin (OR = 6.91 [95% CI: 1.56—30.75]), blended
family (OR = 3.25 [95% CI: 1.25—8.46]) and mean
delay between TST and ﬁrst visit (OR = 1.01 [95%
CI: 1—1.02]) (Table 2).
Completion of treatment
Of the 545 children evaluated for adherence,
61.3% adequately completed the treatment. Fac-
tors decreasing adherence were age >16 years,
delay between TST and ﬁrst visit >15 days and the
presence of relatives >18 years living in the house-
hold in both univariate and multivariate analysis.
Origin of migration, planned treatment’s duration
(6 or 9 months), formulation of isoniazid (pills or
syrup) were, among other factors, not signiﬁcant
for completion (Table 3).
During treatment, 25.1% of the patients reported
complaints. The most frequent were abdominal
pain (4.7%), headaches (4.5%), cough (4.3%), weight
loss (2.8%), asthenia (2%) and vomiting (1.9%). Com-
plaints were not correlated to age or gender. Their
presence did not affect compliance. No case of hep-
atic toxicity or serious adverse events were noted.
e
i
P
a1.58 [1.02—2.43] 1.56 [1.0—2.43]
on ≤120% of these planned at ﬁrst visit.
iscussion
n pediatrics, the goal of TB-screening is to identify
hildren with LTBI who are at risk for progression
o active TB [1,2]. Early treatment of LTBI prevents
xtended and disseminated disease [1,4]. Universal
B school-testing [20,21], with a reported positivity
ate of 2—3%, is not cost-effective [22]. Conversely,
argeted programs have been shown to be cost-
ffective if thresholds of 20% positive children and
0% completion rates are reached [2,23]. Our tar-
eted school-based screening program achieved a
ST positivity rate of 22.8% and good compliance in
1.8%, therefore fulﬁlling these criteria. Our rate
f LTBI was identical to other school-based series
8,15], but, with better case selection, it could
ave been improved. We chose to target at-risk
lassrooms rather than at-risk children [7] in order
o rapidly test a large number of children. How-
ver, the percentage of positive TST would have
een higher in regular classes if we had tested
mmigrant children only. Indeed, children coming
rom an established market economy country rep-
esented 31.8% of tested children, but only 3.7% of
ositive ones. If these low-risk children had been
xcluded from the TB-screening, the rate of pos-
tive TST in the program would have been 32.2%.
revious studies also found that positive TST was
ssociated with migration from a highly endemic
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ountry [8,20,21,24—27]. As reported by others [8],
he risk of having a positive TST was higher in chil-
ren that had resided in an endemic country for a
onger period of time. Older age at time of testing
as not signiﬁcant in our multivariate analysis, but
as reported as a predictor by others [20,21,25,28]
nd in adults [29]. In only one study of children born
n Mexico and immigrating to the United States,
ositive TST rate and age were not associated [27].
s our program targeted ﬁfth and sixth grades in pri-
ary schools, the lack of signiﬁcance for age may
e related to the age homogeneity in our targeted
roup.
To improve the accuracy of the testing in regular
lasses, one could also use a previously validated
uestionnaire [30,31] including contacts with cases
f TB, country of origin or travels (child and
ousehold’s members) in TB-endemic areas, regu-
ar contacts with adults at risk for TB or known HIV
nfection. Educational levels of parents and ethnic-
ty have also been reported as predictors of positive
ST [30]. In such approach, only at-risk children
ould require TST and the program’s effectiveness
ould subsequently improve.
We reported that 89% of positive children were
accinated with BCG, often at birth. Vaccine sta-
us was not collected in negative children. As
great number of negative children were born
n Canada (where BCG is neither mandatory nor
ecommended), we can hypothesize that BCG vac-
ination rate was low in this group. Previous studies
20,21,26,27] report BCG vaccination as a predictor
or positive TST, especially in younger foreign-born
hildren. In our series, the rate of a positive TST
ncreased with age at migration. We believe, as
thers [30], that the positive TST is more likely
elated to an increased duration of TB exposure in
he country of birth, rather than to previous BCG
accination.
We report a refusal of initial evaluation at
he TB-Clinic and treatment refusal in 16.9% of
he cases. Eastern Europeans were more likely to
ecline the treatment. Communication was not a
arrier to evaluation or treatment, as interpreters
ere available when needed. The refusal might
e related to socio-cultural factors: perception of
he disease, personal beliefs concerning the risks
f LTBI, or parent perception that the previous
CG vaccination protected their child. Other par-
nt refusals seemed based on the perception that
he positive TST reﬂected the previous BCG vacci-
ation history rather than LTBI. In some European
ountries, TST is used to verify the BCG vaccine
mmunogenicity and a positive result is said to con-
er protection. The reason for increased refusal
mong blended families in our series was unclear.
c
p
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o73
erhaps, fear of conﬂict with the other parent
esulting from a positive test and treatment might
ave been an inﬂuential factor. It is also possible
hat familial structure reﬂects socio-economical
evels and related beliefs. Socio-anthropologic
tudies are required for a better understanding of
B perception and related behaviours among newly
mmigrating populations.
Quality improvement in LTBI management
equires a timely evaluation [4,32]. We have found
hat a long delay between TST and the TB-clinic
isit was associated with treatment refusal and
oor compliance. Delayed management could lead
arents to doubt the seriousness of a positive LTBI
4].
Our treatment completion rate in LTBI children
as 61.8%. In previous studies, it varied from 20
o 27.6% in south African children <5 years [13,14],
o 56.8% in Israelis 12—13 years old [10], 50—80%
n foreign-born adolescents living in the United
tates [11,12] and 82—92% in children recently
mmigrating to Canada [8,9,15]. Our lower rate
f treatment completion compared to other Cana-
ian series can be explained by our rigid deﬁnition
or adequate adherence: children taking >80% of
he total dose within 120% of the allotted time.
owever, using a larger deﬁnition for comple-
ion in children treated during 9 months (>80%
f the total dose within 1 year), adherence rate
oorly differed (65.1%). Other studies have tried
o determine factors for failure of LTBI treatment
ompletion, both in adults [29,33—43] and in chil-
ren [12,14,15,44,45]. Somatic complaints during
soniazid treatment have been reported in poorly
dherent adolescents, especially in females [46],
ut we did not ﬁnd such an association.
In our study, signiﬁcant social variables for poor
ompletion were age >16 years, and the presence
f relatives >18 years in the household. We believe
his is related to age homogeneity in our popu-
ation and to the collection of socio-demographic
eatures rather than psychosocial ones. Others have
eported good compliance to be associated with
dherence to social norms and behaviours and to
cculturation processes (as reﬂected by a lower
ge, a higher grade, a better parents’ stability and
upervision (especially for the youngest children),
icultural backgrounds, or lesser risk behaviours
eported in compliant children) [45]. Conﬁdence in
he self-ability to adhere treatment and expecta-
ions of health beneﬁts also play a role in treatment
ompletion.
Incentives have been used to improve com-
liance [47,48]. They have been effective when
ombined with nurse management in adults [49]
r with peer counseling in adolescents [48]. Short-
[[
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[
[
[
[
[
[
[
[
[
[
[
[74
term therapy with isoniazid and rifampicin for 3—4
months may also improve adherence to treatment
[4,50] and has been shown to be as effective as
6—12 months of isoniazid [51]. In-school supervised
administration of treatment could also boost treat-
ment completion rate. In the future, speciﬁcity
may be improved by combining interferon -based
assays and TST [52,53]. The high cost of the assay
might be counterbalanced by a reduction in the
number of patients treated.
In summary, a school-based TB-screening pro-
gram is effective if targeted towards recent
immigrant children. Factors of refusal of testing
and treatment seem essentially related to beliefs
and behaviours concerning protection by BCG vac-
cination, risks of LTBI, and ability of TST to detect
disease. Young age contributed to compliance.
Improving adherence to treatment requires a com-
prehension of socio-cultural beliefs and behaviours
involved in LTBI, as well as accessibility to TB-
Clinics.
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